Letter to the Editor
Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis

https://doi.org/10.1016/j.ijcard.2015.03.116Get rights and content

Section snippets

Funding sources

This study was supported by grants from the National Health and Medical Research Council of Australia program grant ID 546272. TVL was supported by post-doctoral research grant 2011062 from the South-Eastern Norwegian Health Authority.

Disclosures

HK has research contracts and served as a consultant to Novartis. TvL has received lecture honoraria from Novartis. RW and PJ are Novartis employees and may own Novartis stocks.

Conflict of interest

The other authors report no relevant conflicts of interest.

References (8)

  • F. Bodey et al.

    Neprilysin inhibitors preserve renal function in heart failure

    Int. J. Cardiol.

    (Jan 20 2015)
  • H. Clark et al.

    Worsening renal function during renin–angiotensin–aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction

    Eur. J. Heart Fail.

    (2014)
  • T.G. von Lueder et al.

    Renin–angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure

    Circ. Heart Fail.

    (2013)
  • J.J. McMurray et al.

    Angiotensin–neprilysin inhibition versus enalapril in heart failure

    N. Engl. J. Med.

    (2014)
There are more references available in the full text version of this article.

Cited by (0)

View full text